IMMUNOQS PTE. LTD.
Country of registration | Singapore |
Registration number | 202203062D |
Local SIC | |
Incorporation date | 26 Jan 2022 |
Company age | 4 years 4 months |
Official entity type | Exempt Private Limited Company |
No. of officers | 9 |
Contact
160 ROBINSON ROAD, #14-04, SINGAPORE BUSINESS FEDERATION CENTER, Singapore 068914
This is the legal entity page of IMMUNOQS PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- IMMUNOQSView MoreSingaporeAt ImmunoQs, we believe every cancer patient is unique. Our core mission is to enhance patient outcomes in modern cancer therapies. We are a spin-off company from the Agency for Science, Technology and Research (A*STAR), Singapore. We offer comprehensive suites of specialized services to clinicians, scientists, and drug developers, focusing on spatial omics, immune monitoring and digital analytics, meticulously tailored to address specific clinical needs and scientific questions in immuno-oncology.
Revenue | < 1m |
Share Capital - Ordinary shares | SGD 130,000 |
Frequently Asked Questions (FAQ)
- What is the address of IMMUNOQS PTE. LTD.?
- Where is IMMUNOQS PTE. LTD.'s headquarter?
- What is IMMUNOQS PTE. LTD.'s contact number?
- What IMMUNOQS PTE. LTD.'s spending power?
- Does IMMUNOQS PTE. LTD. have a presence in the domain it operates in?

